85 related articles for article (PubMed ID: 31816187)
1. cGMP Generation of Human Induced Pluripotent Stem Cells with Messenger RNA.
Ni Y; Zhao Y; Warren L; Higginbotham J; Wang J
Curr Protoc Stem Cell Biol; 2016 Nov; 39(1):4A.6.1-4A.6.25. PubMed ID: 31816187
[TBL] [Abstract][Full Text] [Related]
2. Human-Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions.
Rivera T; Zhao Y; Ni Y; Wang J
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e117. PubMed ID: 32649060
[TBL] [Abstract][Full Text] [Related]
3. Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.
Wiley LA; Anfinson KR; Cranston CM; Kaalberg EE; Collins MM; Mullins RF; Stone EM; Tucker BA
Curr Protoc Stem Cell Biol; 2017 Aug; 42():4A.12.1-4A.12.14. PubMed ID: 28806854
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
Lieu PT
Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
6. Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions.
Macarthur CC; Fontes A; Ravinder N; Kuninger D; Kaur J; Bailey M; Taliana A; Vemuri MC; Lieu PT
Stem Cells Int; 2012; 2012():564612. PubMed ID: 22550511
[TBL] [Abstract][Full Text] [Related]
7. Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.
Shafa M; Yang F; Fellner T; Rao MS; Baghbaderani BA
Front Med (Lausanne); 2018; 5():69. PubMed ID: 29600249
[TBL] [Abstract][Full Text] [Related]
8. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
9. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
10. Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells.
Choi HY; Lee TJ; Yang GM; Oh J; Won J; Han J; Jeong GJ; Kim J; Kim JH; Kim BS; Cho SG
J Control Release; 2016 Aug; 235():222-235. PubMed ID: 27266364
[TBL] [Abstract][Full Text] [Related]
11. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
[TBL] [Abstract][Full Text] [Related]
12. Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies.
Dashtban M; Panchalingam KM; Shafa M; Ahmadian Baghbaderani B
Methods Mol Biol; 2021; 2286():179-198. PubMed ID: 32430594
[TBL] [Abstract][Full Text] [Related]
13. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
14. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
15. Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood.
Tian P; Elefanty A; Stanley EG; Durnall JC; Thompson LH; Elwood NJ
Front Cell Dev Biol; 2022; 10():835321. PubMed ID: 35372371
[TBL] [Abstract][Full Text] [Related]
16. Footprint- and xeno-free human iPSCs derived from urine cells using extracellular matrix-based culture conditions.
Lee KI; Kim HT; Hwang DY
Biomaterials; 2014 Sep; 35(29):8330-8. PubMed ID: 24994040
[TBL] [Abstract][Full Text] [Related]
17. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
[TBL] [Abstract][Full Text] [Related]
18. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
[TBL] [Abstract][Full Text] [Related]
19. Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line.
Zhu J; Reynolds J; Garcia T; Cifuentes H; Chew S; Zeng X; Lamba DA
Stem Cells Transl Med; 2018 Feb; 7(2):210-219. PubMed ID: 29266841
[TBL] [Abstract][Full Text] [Related]
20. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.
Chou BK; Gu H; Gao Y; Dowey SN; Wang Y; Shi J; Li Y; Ye Z; Cheng T; Cheng L
Stem Cells Transl Med; 2015 Apr; 4(4):320-32. PubMed ID: 25742692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
